Hungry Neurons: Metabolic Insights on Seizure Dynamics.
Paolo BazzigaluppiAzin Ebrahim AminiIliya WeisspapirBojana StefanovicPeter L CarlenPublished in: International journal of molecular sciences (2017)
Epilepsy afflicts up to 1.6% of the population and the mechanisms underlying the appearance of seizures are still not understood. In past years, many efforts have been spent trying to understand the mechanisms underlying the excessive and synchronous firing of neurons. Traditionally, attention was pointed towards synaptic (dys)function and extracellular ionic species (dys)regulation. Recently, novel clinical and preclinical studies explored the role of brain metabolism (i.e., glucose utilization) of seizures pathophysiology revealing (in most cases) reduced metabolism in the inter-ictal period and increased metabolism in the seconds preceding and during the appearance of seizures. In the present review, we summarize the clinical and preclinical observations showing metabolic dysregulation during epileptogenesis, seizure initiation, and termination, and in the inter-ictal period. Recent preclinical studies have shown that 2-Deoxyglucose (2-DG, a glycolysis blocker) is a novel therapeutic approach to reduce seizures. Furthermore, we present initial evidence for the effectiveness of 2-DG in arresting 4-Aminopyridine induced neocortical seizures in vivo in the mouse.
Keyphrases
- temporal lobe epilepsy
- cell therapy
- spinal cord
- systematic review
- randomized controlled trial
- stem cells
- blood pressure
- spinal cord injury
- working memory
- positron emission tomography
- type diabetes
- multiple sclerosis
- blood glucose
- oxidative stress
- quality improvement
- endothelial cells
- subarachnoid hemorrhage
- angiotensin ii